LYZ and primary systemic amyloidosis: Collectively, our NMR and MD simulations enable the first direct observation of the lowly populated lysozyme intermediate state and reveal how these disease‐causing structures are stabilized by non‐native interactions, providing a potential structural target for perturbing lysozyme fibril formation in systemic amyloidosis.